Lung Cancer

CURE® took a look back at our most-read lung cancer stories from this year.

A cancer survivor describes an inspiring close friend who has been dealing with cancer for 13 years and refuses to give up.

A woman explains how her close friend achieved remission from stage 4 lung cancer after being treated by Dr. Bret Friday – a superhero in her book.

From Kathy Griffin sharing that she is now cancer free to Michael Bublé discussing his son’s cancer journey, here’s what’s happening in the cancer landscape this week.

A lung cancer survivor explains how a serendipitous friendship with her stepson’s girlfriend’s aunt changed her life.

The first patient was randomized in the phase 2 trial examining Tedopi and Opdivo for non-small cell lung cancer.

A patient with lung cancer explains how Dusty Donaldson's work for patients and survivors has inspired and touched the lives of many people.

Dr. Roman Perez-Soler received his original training in Spain but has been a constant beloved presence in the U.S. lung cancer arena for more than 30 years.

Simply put, Jan Poulsen is an inspiration to those diagnosed with lung cancer, a friend writes.

Lilian is a gentle soul who was placed on Earth for this purpose: to guide those with the most common cancer there is.

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

A colleague explains how Jody Ruth Steinhardt helps guide patients through lung cancer screenings and offers them support.

A colleague describes how Suzanne Walker has touched the lives of many patients with lung cancer over the years.

An oncologist explains why Tami Tittlefitz, a lung cancer nurse practitioner, is "one of a kind: a saint and a healer."

A lung cancer survivor explains how Dr. Brendon Stiles is an asset to the lung cancer community. "He is such an accomplished thoracic surgeon, but he is so humble and generous with his time."

It is my hope that the cancer field continues to grow the novel therapy for not only patients with lung cancer, but well beyond. It is critical that the public be aware of how research and clinical trials are catalysts to better the outcomes of patients with cancer.

Targeted therapies offer new hope for patients with HER2-mutated non-small cell lung cancers.

A patient with stage 4 lung cancer explains why Dr. Shirish Gadgeel is a ray of sunshine and hope who makes patients with cancer feel that living a long life is a possibility.

Christine Eastep demonstrates the highest commitment to every one of the patients and her staff to improve the outcomes in lung cancer treatment, with a commitment to sending her staff nurses to tobacco cessation classes.

Dr. Roy H. Decker is a lung cancer hero — a “triple threat” in lung radiation oncology as a clinical innovator, teacher and ground-breaking clinical trialist, explains a colleague.

Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.

Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.

Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.

"Having been newly diagnosed myself, I saw how amazingly well she was doing and had been a survivor for about three years already," a lung cancer survivor writes about a connection she made with another survivor.

A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.

A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.

Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.

Out of the darkness there is sometimes light, and in South Florida, Dr. Mark Block is a beacon of hope and light for many patients who’ve recently received a diagnosis of cancer.

On this episode of the “Cancer Horizons” podcast, a young mother living with lung cancer shares the story of her cancer diagnosis and describes the once-in-a-lifetime coincidence of learning her neighbor has the same cancer type and mutation.